URL copied
Canada s largest province halts AstraZeneca doses over blood clot concerns
Canada s largest province said Tuesday it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots. Ontario s chief medical officer for health, Dr. David Williams, said the decision was made out of an abundance of caution because of increased instances of the rare blood clotting disorder linked to the shot. AstraZeneca is restricted in some European countries because of a potential link to extremely rare blood clots.
âOver the last few days there have been increased reports,â Williams said.
/PRNewswire/ Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition.
One day after the province of Alberta said it would suspend administering the first dose of the Oxford AstraZeneca vaccine, the province of Ontario said it was also suspending giving AstraZeneca and Covishield as a first dose as a defence against COVID-19. Covishield is the AstraZeneca vaccine made under licence in India. Alberta cited lack…